Pleryon Therapeutics

📍 Shenzhen, China🗓 Founded 2017👥 7 employees💰 Last funded Nov 2025
Biotechnology Research🌐 pleryon.com
Website LinkedIn
Pleryon Therapeutics is a preclinical stage biotech startup company. Our mission is to develop novel polymer-based therapeutics to address global unmet medical needs related to aging. Since its formal operation in 2020, Pleryon has raised closed to RMB 100 million from top biotech private investors. Pleryon is advancing its diverse pipelines in multiple disease areas, including ophthalmology, orthopedics, and tissue regeneration.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2017
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
Switzerland
1
Frequently asked questions
Who invested in Pleryon Therapeutics?
Pleryon Therapeutics has 1 investor on record on gritt.io and 1 late-stage investors.
When did Pleryon Therapeutics last raise funding?
The most recent investment in Pleryon Therapeutics recorded on gritt.io was in November 2025.
When was Pleryon Therapeutics founded?
Pleryon Therapeutics was founded in 2017.
What industry is Pleryon Therapeutics in?
Pleryon Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Pleryon Therapeutics based?
Pleryon Therapeutics is headquartered in Shenzhen, China.